Baseline demographic and clinical characteristics of the study participants
| V+A group (n=48) | V+T group (n=49) | |
| Age (years) | 68±10 | 68±10 |
| Men | 21 (44) | 21(43) |
| Body height (cm) | 156.0±10.0 | 156.9±8.1 |
| BMI (kg/m2) | 24.9±3.8 | 24.7±3.6 |
| Dyslipidaemia | 21(44) | 22 (44) |
| Diabetes mellitus | 7 (14) | 4 (8) |
| Chronic kidney disease | 29 (60) | 29 (59) |
| Current smoking | 10 (21) | 6 (12) |
| Previous CVD | 10 (21) | 10 (20) |
| Hypoglycaemic drugs | 7 (14) | 2 (4) |
| Statins | 16 (33) | 15 (31) |
Data are expressed as the mean±SD or the number (percentage).
BMI, body mass index; CVD, cardiovascular disease; V+A, valsartan with aliskiren; V+T, valsartan with trichlormethiazide.